Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial

1. McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS. 2012;26(14):1735–8. doi: 10.1097/QAD.0b013e328355d67b 22614888.

2. UNAIDS. UNAIDS Website. Accessed May 24, 2016 at: http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2015/july/20150714_PR_MDG6report.

3. UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Accessed May 1, 2016 at: http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf.

4. Fox MP, Rosen S. Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008–2013. J Acquir Immune Defic Syndr. 2015;69(1):98–108. doi: 10.1097/QAI.0000000000000553 25942461; PubMed Central PMCID: PMC4422218.

5. Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;17(12):1509–20. Epub 2012/09/22. doi: 10.1111/j.1365-3156.2012.03089.x 22994151; PubMed Central PMCID: PMC3895621.

6. McNairy ML, Lamb MR, Abrams EJ, Elul B, Sahabo R, Hawken MP, et al. Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries. J Acquir Immune Defic Syndr. 2015;70(2):e44–51. doi: 10.1097/QAI.0000000000000745 26375466.

7. Fox MP, Shearer K, Maskew M, Meyer-Rath G, Clouse K, Sanne I. Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa. PLoS ONE. 2014;9(10):e110252. doi: 10.1371/journal.pone.0110252 25330087; PubMed Central PMCID: PMC4203772.

8. Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, et al. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLoS Med. 2016;13(8):e1002107. doi: 10.1371/journal.pmed.1002107 27504637; PubMed Central PMCID: PMC4978506.

9. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67. Epub 2012/07/12. doi: 10.1097/QAD.0b013e3283578b9b 22781227.

10. Hall BJ, Sou KL, Beanland R, Lacky M, Tso LS, Ma Q, et al. Barriers and Facilitators to Interventions Improving Retention in HIV Care: A Qualitative Evidence Meta-Synthesis. AIDS Behav. 2016;21(6):1755–67. doi: 10.1007/s10461-016-1537-0 27582088.

11. Fox MP, Rosen S, Geldsetzer P, Barnighausen T, Negussie E, Beanland R. Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness. J Int AIDS Soc. 2016;19(1):20888. 10.7448/IAS.19.1.20888. 27507249; PubMed Central PMCID: PMC4978859. doi: 10.7448/IAS.19.1.20888 27507249

12. Govindasamy D, Meghij J, Kebede Negussi E, Baggaley RC, Ford N, Kranzer K. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings—a systematic review. J Int AIDS Soc. 2014;17:19032. doi: 10.7448/IAS.17.1.19032 25095831; PubMed Central PMCID: PMC4122816.

13. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, et al. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016;3(11):e539–e48. doi: 10.1016/S2352-3018(16)30090-X 27658873.

14. Koenig SP, Dorvil N, Devieux JG, Hedt-Gauthier BL, Riviere C, Faustin M, et al. Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial. PLoS Med. 2017;14(7):e1002357. doi: 10.1371/journal.pmed.1002357 28742880; PubMed Central PMCID: PMC5526526.

15. McNairy ML, Gachuhi AB, Lamb MR, Nuwagaba-Biribonwoha H, Burke S, Ehrenkranz P, et al. The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial. Implementation science: IS. 2015;10:101. doi: 10.1186/s13012-015-0291-4 26189154; PubMed Central PMCID: PMC4506770.

16. Institute for Health Metrics and Evaluation. IHME Health Data Swaziland. Accessed May 30, 2017 at: http://www.healthdata.org/swaziland.

17. Justman J, Reed JB, Bicego G, Donnell D, Li K, Bock N, et al. Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study. Lancet HIV. 2016;4(2):e83–e92. doi: 10.1016/S2352-3018(16)30190-4 27863998.

18. CDC In Swaziland. Swaziland Health Factsheet. Accessed November 15 2013 at: https://www.cdc.gov/globalhealth/countries/swaziland/pdf/swaziland_factsheet.pdf.

19. The World Band. Swaziland HIV Data. Accessed December 20 2016 at: http://data.worldbank.org/indicator/SH.HIV.ARTC.ZS.

20. Auld AF, Kamiru H, Azih C, Baughman AL, Nuwagaba-Biribonwoha H, Ehrenkranz P, et al. Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services. J Acquir Immune Defic Syndr. 2015;69(1):e1–e12. doi: 10.1097/QAI.0000000000000547 25942465.

21. MacKellar DA, Williams D, Storer N, Okello V, Azih C, Drummond J, et al. Enrollment in HIV Care Two Years after HIV Diagnosis in the Kingdom of Swaziland: An Evaluation of a National Program of New Linkage Procedures. PLoS ONE. 2016;11(2):e0150086. doi: 10.1371/journal.pone.0150086 26910847; PubMed Central PMCID: PMC4766101.

22. The Kingdom of Swaziland Ministry of Health. Annual HIV Programs Report 2015. Mbabane, Swaziland: Swaziland Ministry of Health, 2015.

23. Larson BA, Brenna A, McNamara L, Long L, Rosen S, Sanne I, et al. Lost Opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ. 2010;88(9):675–80. doi: 10.2471/BLT.09.068981 20865072.

24. Jani IV, Sitoe NE, Alfai ER, Chong PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011;378(9802):1572–9. doi: 10.1016/S0140-6736(11)61052-0 21951656.

25. Faal M, Naidoo N, Glenncross DK, Venter WD, Osih R. Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr. 2011;58(3):e54–9. doi: 10.1097/QAI.0b013e3182303921 21857356.

26. Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr. 2012;61(2):e13–7. doi: 10.1097/QAI.0b013e31825eec60 22659650; PubMed Central PMCID: PMC3458178.

27. Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Wu Y, et al. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved. 2013;24(1):359–83. doi: 10.1353/hpu.2013.0014 23377739; PubMed Central PMCID: PMC3655523.

28. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. Epub 2011/07/20. doi: 10.1056/NEJMoa1105243 21767103; PubMed Central PMCID: PMC3200068.

29. Chang L, Kagaayi J, Nakigozi G, Packer AH, Serwadda D, Quinn TC, et al. Responding to the human resource crisis: peer health workers, mobile phones, and HIV care in Rakai, Uganda. AIDS Patient Care STDS. 2008;22(3):173–4. doi: 10.1089/apc.2007.0234 PubMed Central PMCID 2674572 18290750

30. Downer SR, Mear JG, Da Costa AC, Sethuraman K. SMS text messaging improves outpatient attendance. Aust Health Rev. Aug 2006;30(3):389–96. 16879098.

31. Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. Feb 2009;36(2):165–73. doi: 10.1016/j.amepre.2008.09.040 19135907.

32. Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. Dec 2010;14(6):1294–301. doi: 10.1007/s10461-010-9720-1 20532605.

33. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. Nov 27 2010;376(9755):1838–45. doi: 10.1016/S0140-6736(10)61997-6 21071074.

34. Liew SM, Tong SF, Lee VK, Ng CJ, Leong KC, Teng CL. Text messaging reminders to reduce non-attendance in chronic disease follow-up: a clinical trial. Br J Gen Pract. Dec 2009;59(569):916–20. doi: 10.3399/bjgp09X472250 19712544.

35. Mukund Bahadur KC, Murray PJ. Cell phone short messaging service (SMS) for HIV/AIDS in South Africa: a literature review. Stud Health Technol Inform. 2010;160(Pt 1):530–5. 20841743.

36. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. Mar 27 2011;25(6):825–34. doi: 10.1097/QAD.0b013e32834380c1 21252632.

37. Shet A, de Costa A. India calling: harnessing the promise of mobile phones for HIV healthcare. Trop Med Int Health. 2011;16(2):214–6. doi: 10.1111/j.1365-3156.2010.02678.x 21371214.

38. Colindres P, Mermin J, Ezati E, Kambabazi S, Buyungo P, Sekabembe L, et al. Utilization of a basic care and prevention package by HIV-infected persons in Uganda. AIDS Care. 2008;20(2):139–45. Epub 2007/09/27. doi: 10.1080/09540120701506804 17896196.

39. Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997;315(7110):703–7. Epub 1997/10/07. 9314754; PubMed Central PMCID: PMC2127496.

40. Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631–7. Epub 2008/12/11. doi: 10.1001/jama.2008.804 19066383.

41. Volpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272. Epub 2008/12/24. doi: 10.1186/1472-6963-8-272 19102784; PubMed Central PMCID: PMC2635367.

42. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009;360(7):699–709. Epub 2009/02/14. doi: 10.1056/NEJMsa0806819 19213683.

43. Charness G, Gneezy U. Incentives to exercise. Econometrica. 2009;77(3):909–31.

44. Marcus AC, Kaplan CP, Crane LA, Berek JS, Bernstein G, Gunning JE, et al. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care. 1998;36(3):397–410. Epub 1998/04/01. 9520963.

45. Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health. 1998;88(5):792–6. Epub 1998/05/20. 9585747; PubMed Central PMCID: PMC1508952.

46. WHO. Technical and Operational Considerations for Implementing HIV Viral Load Testing. Geneva: WHO, 2014.

47. Snijders TA, Bosker RJ. Multilevel analysis: An introduction to basic and advanced mulitlevel modeling. Thousand Oaks, California: Sage; 1999.

48. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: WHO, 2015 September 2015.

49. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS. 2014;28(4):589–98. doi: 10.1097/QAD.0000000000000143 24468999; PubMed Central PMCID: PMC4009400.

50. Columbia University. The Population HIV Impact Assessment (PHIA) Project. Accessed May 31 2017 at: www.phia.icap.columbia.edu.

51. Justman J. Real Progress in the HIV Epidemic: PHIA Findings from Zimbabwe, Malawi, and Zambia. Oral Abstract. Conference of Retroviruses and Opportunistic Infections February 13–15, 2017; Seattle, WA2017.

52. Nkambule R, Nuwagaba-Biribownwoha H, Mnisi Z, Ao T, Duong Y, Patel H, et al. Substantial progress in confronting the HIV epidemic in Swaziland: first evidence of national impact. Abstract 204LB. International AIDS Society 2017; July 24, 2017; Paris, France 2017.

53. El-Sadr WM, Donnell D, Beauchamp G, Hall HI, Torian LV, Zingman B, et al. Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065). JAMA. 2017;177(8):1083–92. doi: 10.1001/jamainternmed.2017.2158 28628702.

54. Geng EH, Glidden DV, Bwana MB, Musinguzi N, Emenyonu N, Muyindike W, et al. Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS ONE. 2011;6(7):e21797. doi: 10.1371/journal.pone.0021797 21818265; PubMed Central PMCID: PMC3144217.

55. Giordano TP, Gifford AL, White AC Jr., Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493–9. Epub 2007/05/08. doi: 10.1086/516778 17479948.

56. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial. PLoS Med. 2016;13(5):e1002015. doi: 10.1371/journal.pmed.1002015 27163694.